VERSANT VENTURE CAPITAL VI, L.P. sold 8.3% of their position (567.21K shares) of MONTE ROSA THERAPEUTICS, INC. on the open market
Open‑market sale worth $3.40M — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 3 sales
Filed: 9/13/2024ACC: 0000950170-24-106532
10% Owner
Since Jun 2021
-567.21K
Net shares
Net seller
$3.40M
Total sold
3
Open market trades
0B · 3S
3
Total transactions
567.21K disposed
Non-Derivative Transactions3
Common Stock
Direct
Shares
−541.90K
Price / share
$6.00
Trade value
$3.25M
% of position
8.0%
9/11/2024
6.80M→6.26M
Common Stock
Direct
Shares
−16.05K
Price / share
$6.00
Trade value
$96.31K
% of position
0.3%
9/12/2024
6.26M→6.24M
Common Stock
Direct
Shares
−9.27K
Price / share
$6.16
Trade value
$57.10K
% of position
0.1%
9/13/2024
6.24M→6.23M
Total
Net shares
−567.21K
Net value
-$3.40M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/11/2024 | S · Sale | −541.90K | $6.00 | $3.25M | 8.0% | 6.80M | 6.26M |
| Common Stock Direct | 9/12/2024 | S · Sale | −16.05K | $6.00 | $96.31K | 0.3% | 6.26M | 6.24M |
| Common Stock Direct | 9/13/2024 | S · Sale | −9.27K | $6.16 | $57.10K | 0.1% | 6.24M | 6.23M |
| Total | −567.21K | -$3.40M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
IndirectShares owned2.10M
Total
2.10M indirect2.10M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 2.10M | Indirect |
| Total | 2.10M | 2.10M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported